Primary Record
Bromosporine
- In stock
- 1,577 g
- Purity
- 99.1 %
- CAS
- 1619994-69-2
Compound Identifiers & Properties
- CAS
- 1619994-69-2
- PubChem CID
- 72943187
- SMILES
- CCOC(=O)NC1=CC(=NN2C1=NN=C2C)C3=CC(=C(C=C3)C)NS(=O)(=O)C
- Canonical SMILES
- CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12
Names & Synonyms
- Bromosporine
- 1619994-69-2
- Bioomosporine
- Bromorsporine
- Bromosporine?
- Bromosporine & TNF-a
- RefChem:121639
- Bromosporine & TNF-alpha
- Bromosporine & TNF-.a.
- D07ALG
- Bromosporine & TNF-.alpha.
- CHEMBL3133807
- C17H20N6O4S
- MFCD26142669
- GTPL8234
- orb1300932
- SCHEMBL17359131
- AOB6807
- Bromosporine, >=98% (HPLC)
- GLXC-04090
- HMS3653C21
- KS-00000T5O
- 2286AH
- BDBM50504160
- NSC768126
- s7233
- ZINC95616589
- AKOS024458332
- ACN-034716
- CCG-268692
- CS-3240
- NSC-768126
- NCGC00351471-11
- AK175193
- AS-75091
- BB170570
- BP-25350
- DA-61904
- HY-15815
- QC-10870
- Bromosporine & Tumor necrosis factor alpha
- Bromosporine & Tumor necrosis factor-alpha
- A4186
- SW219727-1
- ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate
- J3.656.836D
- A13163
- C73098
- A904240
- Carbamic acid, N-[3-methyl-6-[4-methyl-3-[(methylsulfonyl)amino]phenyl]-1,2,4-triazolo[4,3-b]pyridazin-8-yl]-, ethyl ester
- BRD-K44665581-001-01-8
- Q27075529
- ethyl N-[6-(3-methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate
- ethyl N-[6-[3-(methanesulfonamido)-4-methyl-phenyl]-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate
- ethyl N-[6-[3-(methanesulfonamido)-4-methylphenyl]-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate
- 4H2
- 7-Methyl-2-[4-methyl-3-(methylsulfonylamino)phenyl]-4-(ethoxycarbonylamino)-5,6-diazapyrrolo[1,2-b]pyridazine
- Carbamic acid, N-(3-methyl-6-(4-methyl-3-((methylsulfonyl)amino)phenyl)-1,2,4-triazolo(4,3-b)pyridazin-8-yl)-, ethyl ester
- Ethyl (3-Methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate; Ethyl N-[3-methyl-6-[4-methyl-3-[(methylsulfonyl)amino]phenyl]-1,2,4-triazolo[4,3-b]pyridazin-8-yl]carbamate (ACI);Carbamic acid, N-(3-methyl-6-(4-methyl-3-((methylsulfonyl)amino)phenyl)-1,2,4-triazolo(4,3-b)pyridazin-8-yl)-, ethyl ester; Ethyl (3-methyl-6-(4-methyl-3-((methylsulfonyl)amino)phenyl)(1,2,4)triazolo(4,3-b)pyridazin-8-yl)carbamate
- ethyl (3-methyl-6-{4-methyl-3-[(methylsulfonyl)amino]phenyl}[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate
- ethyl 3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-ylcarbamate
- ethyl N-(6-(3-methanesulfonamido-4-methylphenyl)-3-methyl-(1,2,4)triazolo(4,3-b)pyridazin-8-yl)carbamate
- N-[(6-3-Methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate